Joseph Kim, Inovio CEO (Andrew Harnik, AP Images)
Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it's in legal feud with; Cyberattacks spotted targeting vaccine distribution
With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
